Jwmc. Cruz et al., Influence of tolrestat on the defective leukocyte-endothelial interaction in experimental diabetes, EUR J PHARM, 391(1-2), 2000, pp. 163-174
One of the most devastating secondary complications of diabetes is the blun
ted inflammatory response that becomes evident even in the very early stage
s of poorly controlled diabetes mellitus. While the etiology of this dimini
shed response is not clearly understood, it has been linked to a decrease i
n the respiratory burst of neutrophils, as well as a decrease in microvesse
l response to inflammatory mediators and defective leukocyte-endothelial in
teractions. Using video microscopy to visualize vessels of the internal spe
rmatic fascia, we have characterized leukocyte-endothelial interactions in
alloxan induced diabetic and in galactosemic rats by quantitating the numbe
r of leukocytes rolling along the venular endothelium and the number of leu
kocytes sticking to the vascular wall after topical application of zymosan-
activated plasma or leukotriene B-4 (1 ng/ml), as well as after the applica
tion of a local irritant stimulus (carrageenan, 100 mu g). We observed that
while 33 days of alloxan-induced diabetes or 7 days of galactosemia had no
effect on total or differential leukocyte counts and on the wall shear rat
e, both treatments significantly (P < 0.001) reduced the number of leukocyt
es rolling along the venular endothelium by about 70% and the number of adh
ered leukocytes in postcapillary venules by 60%. These effects were not obs
erved in diabetic and galactosemic animals treated with an aldose reductase
inhibitor. Thr results suggest that impaired leukocyte-endothelial cell in
teractions are a consequence of an enhanced flux through the polyol pathway
. (C) 2000 Elsevier Science B.V. All rights reserved.